1 - 2 of 2
1
Conference icon

Conference

Value of molecular monitoring for minimal residual disease preceding autologous SCT following diagnosis of B cell acute lymphoblastic leukemia in patients treated with the MRC UKALL12 protocol.

  • Foroni, L, Mitchell, W, Rai, LJ, et al.
  • 2005-11-16
2
Conference icon

Conference

Molecular monitoring of residual disease (MRD) during induction and intensification phases in low risk adult B cell ALL treated according to the MRC UKALL12 protocol.

  • Foroni, L, Mitchell, W, Rai, LJ, et al.
  • 2005-11-16
FILTER RESULTS

TO TOP